Tazarotene 0.1% gel for refractory mycosis fungoides lesions: an open-label pilot study

Practical Non-Parametric Statistics.

B. M. Brown, W. J. Conover · Biometrics · 1981 · 2.4K citations

Bexarotene Is Effective and Safe for Treatment of Refractory Advanced-Stage Cutaneous T-Cell Lymphoma: Multinational Phase II-III Trial Results

Madeleine Duvic, Kenneth B. Hymes, Peter Heald et al. · Journal of Clinical Oncology · 2001 · 704 citations

Medicine, Oncology, Pharmacology +14

Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma.

Madeleine Duvic, Ángel G. Martín, Y. Kim et al. · PubMed · 2001 · 438 citations

Medicine, Pharmacology, Pharmacotherapy +14

Clinical Stage IA (Limited Patch and Plaque) Mycosis Fungoides

Youn H. Kim · Archives of Dermatology · 1996 · 284 citations

Medicine, Oncology, Pathology +11

Phase 1 and 2 Trial of Bexarotene Gel for Skin-Directed Treatment of Patients With Cutaneous T-Cell Lymphoma

Debra Breneman, Madeleine Duvic, Timothy M. Kuzel et al. · Archives of Dermatology · 2002 · 210 citations

Medicine, Oncology, Pharmacology +15